Gyre Therapeutics
GYRE
GYRE
34 hedge funds and large institutions have $2.63M invested in Gyre Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Holders
34
Holding in Top 10
–
Calls
$173K
Puts
–
Top Buyers
| 1 | +$132K | |
| 2 | +$45.2K | |
| 3 | +$22.7K | |
| 4 |
Jane Street
New York
|
+$16.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$13.8K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$370K | |
| 3 | -$51K | |
| 4 |
Goldman Sachs
New York
|
-$46K |
| 5 |
VF
Virtu Financial
New York
|
-$30.5K |